Tylenol w/ codeine no. 3 and Arimidex drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tylenol w/ codeine no. 3 (acetaminophen; codeine phosphate) and Arimidex (anastrozole). Common drug interactions include nausea among females.
The phase IV clinical study analyzes what interactions people have when they take Tylenol w/ codeine no. 3 and Arimidex. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.
What is Tylenol w/ codeine no. 3?
Tylenol w/ codeine no. 3 has active ingredients of acetaminophen; codeine phosphate. It is often used in pain. eHealthMe is studying from 4,920 Tylenol w/ codeine no. 3 users. Check the latest studies of Tylenol w/ codeine no. 3.
What is Arimidex?
Arimidex has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 22,642 Arimidex users. Check the latest studies of Arimidex.
25 people who take Tylenol w/ codeine no. 3 and Arimidex together, and have interactions are studied.

What are the common drug interactions of Tylenol W/ Codeine No. 3 and Arimidex, by gender? *:
female:
- Nausea (feeling of having an urge to vomit)
- Bone pain
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Weight decreased
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Body temperature increased
- Bone disorder
- Emotional distress
- Epistaxis (bleed from the nose)
- Infection
male:
n/a
What are the common drug interactions of Tylenol W/ Codeine No. 3 and Arimidex, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Vomiting
- Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
- Oral surgery
- Ovarian cyst (fluid filled sac of the ovary)
- Pain in jaw
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Osteonecrosis of jaw (death of bone of jaw)
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Scapula fracture (a fracture of the scapula, the shoulder blade)
- Skin hyperpigmentation (disorders affect the colour of your skin)
50-59:
- Dental caries
- Asthenia (weakness)
- Balance disorder
- Cardiac failure congestive
- Chapped lips (cracking, fissuring, and peeling of the skin f lip)
- Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Dyspnoea (difficult or laboured respiration)
60+:
- Nausea (feeling of having an urge to vomit)
- Weight decreased
- Blood glucose increased
- Burning sensation
- Cellulitis (infection under the skin)
- Diarrhoea
- Diplopia (double vision)
- Erythema (redness of the skin)
- Foot fracture
- Heart rate increased
What are the existing conditions these people have? *
- Metastases To Bone (cancer spreads to bone): 4 people, 16.00%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 16.00%
- Type 2 Diabetes: 3 people, 12.00%
- Swelling: 3 people, 12.00%
- Neuropathy Peripheral (surface nerve damage): 3 people, 12.00%
- Joint Pain: 3 people, 12.00%
- High Blood Cholesterol: 3 people, 12.00%
- Osteoporosis (bones weak and more likely to break): 2 people, 8.00%
- Migraine (headache): 2 people, 8.00%
- Gastrointestinal Hypomotility (less activity of the intestinal tract): 2 people, 8.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tylenol w/ codeine no. 3 and Arimidex?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Tylenol w/ codeine no. 3 (4,920 reports)
- Arimidex (22,642 reports)
Browse all drug interactions of Tylenol w/ codeine no. 3 and Arimidex:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tylenol w/ codeine no. 3:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Arimidex:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tylenol w/ codeine no. 3 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Arimidex and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
- Manjunatha N, Ganjekar S, Mahendra JV, Kilara N, Srinivasa R, "Tardive Dyskinesia Associated With Anastrozole", The Journal of neuropsychiatry and clinical neurosciences, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on acetaminophen; codeine phosphate and anastrozole (the active ingredients of Tylenol w/ codeine no. 3 and Arimidex, respectively), and Tylenol w/ codeine no. 3 and Arimidex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cyclosporine cause Crohn'S Disease? - 8 seconds ago
- Imdur vs. Metoprolol Tartrate, side effect and effectiveness comparison - 11 seconds ago
- Drug interactions of Tramadol and Estrace - 34 seconds ago
- Drug interactions of Hydrocortisone Valerate and Ketoconazole - 38 seconds ago
- Could Thalidomide cause Transaminases Increased? - 39 seconds ago
- Drug interactions of Alinia and Oxycodone - 40 seconds ago
- Drug interactions of Deflazacort and Meropenem - 40 seconds ago
- Could Isoniazid cause Hearing Loss? - 46 seconds ago
- Drug interactions of Keppra and Vascepa - 50 seconds ago
- Drug interactions of Mysoline and Solu-Cortef - 54 seconds ago